Articles by Murray Aitken - Pharmaceutical Executive

ADVERTISEMENT

Articles by Murray Aitken

Murray Aitken


Back Page: Withdrawal Syndrome
December 1, 2004

There's nothing like a product withdrawal to put the pharmaceutical industry under the microscope. Following Merck's decision to withdraw Vioxx from the market, a flurry of reports in the US media suggested a need to re-examine and overhaul everything from the drug approval process, to direct-to-consumer advertising, to the way pharma handles R&D. Our challenge as an industry is to use the Vioxx case as a catalyst for making thoughtful improvements to our current practices—improvements that build on the many things we are doing right.

ADVERTISEMENT

Click here